HomeLonza to buy back $2.17 billion worth of shares, backs mid-term growthFILE PHOTO: Logo of Swiss contract drug maker Lonza is

FILE PHOTO: Logo of Swiss contract drug maker Lonza is

FILE PHOTO: The logo of Swiss contract drug maker Lonza is seen at its headquarters in Basel, Switzerland October 1, 2020. REUTERS/Arnd Wiegmann/File Photo

Walgreens Boots signals turnaround on track as it tops estimates, shares surge

January 10, 2025

Pfizer must face lawsuit over diversity fellowship program, US court rules

January 10, 2025

Greenland’s leader ready to talk to Trump

January 10, 2025

Exclusive-Western powers warn Syria over foreign jihadists in army, sources say

January 10, 2025

FILE PHOTO: Logo of Swiss contract drug maker Lonza is

Most Read

Walgreens Boots signals turnaround on track as it tops estimates, shares surge

Pfizer must face lawsuit over diversity fellowship program, US court rules

Greenland’s leader ready to talk to Trump

Exclusive-Western powers warn Syria over foreign jihadists in army, sources say

EDITOR PICKS

Walgreens Boots signals turnaround on track as it tops estimates, shares surge

Pfizer must face lawsuit over diversity fellowship program, US court rules

Greenland’s leader ready to talk to Trump

POPULAR POSTS

Walgreens Boots signals turnaround on track as it tops estimates, shares surge

Pfizer must face lawsuit over diversity fellowship program, US court rules

Greenland’s leader ready to talk to Trump

POPULAR CATEGORY